Industry Insight
Discovery Technology
Analytical Laboratory Technology
Biopharma
Manufacturing
Delivery Systems
Ingredients, Formulation and Finishing
Bioprocessing
View our other publications with free access to extensive archives
  To print this article:
Existing subscribers please log in:
 
  USER NAME  
  PASSWORD  
   Or select

Or become a subscriber
 
 
 

Pharma 2020: Challenging Business Models

Pharma’s fully integrated business model is under huge pressure and by 2020 no pharma company will be able to ‘profit alone’; instead, companies will have to collaborate with other organisations, both inside and outside the sector. A recent report puts forward two business models that are likely to emerge as companies prepare for this future.

By Jo Pisani and Steve Arlington at PricewaterhouseCoopers (September 2009)

Keywords: business models, pharma, profit, federated model, management hub, big pharma, federation

    View full article    |    Back to Industry Insight section




Advair,Flovent,VentolinSymbicort,Serevent,FlonaseAstelin Rhinocort
IPTonline © 2004 The Pharmaceutical Technology Journal | Terms and Conditions | info@iptonline.com | UK Contacts |
Providing a platform of communication on new ideas, developments and innovations | UK Tel No. +44 20 77243456 | Back to top of page |